PTPRJ and metabolic disease: Targeted drug interventions for levels of PTPs in disease have been widely described, and these drugs have shown good experimental results in disease models; however, to date, there are no clinically approved drugs for PTPRJ, and further research is needed on drug interventions for PTPRJ levels for the clinical treatment of metabolic diseases or cancer.